Expression of AC133 and CD117 on candidate normal stem cell populations in childhood B-cell precursor acute lymphoblastic leukaemia

Br J Haematol. 1999 Dec;107(3):572-80. doi: 10.1046/j.1365-2141.1999.01746.x.

Abstract

To identify residual candidate normal progenitor/stem cell populations in childhood B-cell precursor acute lymphoblastic leukaemia (ALL), expression of AC133 and CD117 was analysed on the leukaemic cell clone and on immature B-lineage-negative CD34+CD19- bone marrow cells. 10/25 patients (40%) had no detectable expression of AC133 within the leukaemic cell clone. 24/26 patients (92%) lacked expression of CD117 on the leukaemic blast cell population. In contrast, a distinct AC133-positive cell population was found in 8/8 children with AC133-negative ALL and a CD117-positive cell population could be identified in 12/12 children with CD117-negative ALL, within the CD34+CD19- progenitor/stem cell compartment. These observations provide further evidence that in B-cell precursor ALL, unlike in acute myelogenous leukaemia, it may be possible to distinguish residual normal progenitor/stem cells from the leukaemic cell clone.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AC133 Antigen
  • Antigens, CD
  • Antigens, CD19 / metabolism
  • Antigens, CD34 / metabolism
  • Child
  • Flow Cytometry
  • Glycoproteins / metabolism*
  • Humans
  • Leukocyte Common Antigens / metabolism
  • Peptides / metabolism*
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / metabolism*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / metabolism*
  • Proto-Oncogene Proteins c-kit / metabolism*
  • Reverse Transcriptase Polymerase Chain Reaction / methods
  • Stem Cells / metabolism

Substances

  • AC133 Antigen
  • Antigens, CD
  • Antigens, CD19
  • Antigens, CD34
  • Glycoproteins
  • PROM1 protein, human
  • Peptides
  • Proto-Oncogene Proteins c-kit
  • Leukocyte Common Antigens